Cav3.2 is a calcium channel of the T-type that is involved in many processes in the brain and other tissues. Contrary to other calcium channels Cav3.2 is activated by relatively low/negative voltages. Cav3.2 is not a classic cannabinoid receptor but its activity is modulated by cannabinoids. Since cannabinoids have a physiological effect on Cav3.2 it is effectively a cannabinoid receptor.
http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=536&familyId=80&familyType=IC
http://en.wikipedia.org/wiki/CACNA1H
NarGly NADA Anandamide 2AG CBD Δ9THC
References:
Pertwee, R.G., Howlett, A.C., Abood, M.E., Alexander, S.P.H., Di Marzo, V., Elphick, M.R., Greasley, P.J., Hansen, H.S., Kunos, G., Mackie, K., et al. (2010). International Union of Basic and Clinical Pharmacology. LXXIX. cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol. Rev. 62, 588–631.
Kidney > liver > heart, brain.> lung, skeletal muscle, pancreas, placenta. Putamen > amygdala, caudate nucleus > frontal lobe, hippocampus, cerebellum, substantia nigra > thalamus > medulla, spinal cord, occipital lobe, temporal lobe.
For an interactive version, please visit https://www.proteinatlas.org
